Analyst Recommendations

H.C. Wainwright analyst issues UNDERPERFORM recommendation for CPRX on June 3, 2024 09:00AM ET. The previous analyst recommendation was Underperform.CPRX was trading at $16.38 at issue of the...

June 3, 2024   CPRX -0.68%

BMO Capital analyst issues OUTPERFORM recommendation for GROY on June 3, 2024 09:32AM ET. GROY was trading at $1.66 at issue of the analyst recommendation.The overall analyst consensus...

June 3, 2024   GROY 3.66%

Wedbush analyst issues MARKET PERFORM recommendation for OKTA on June 3, 2024 10:00AM ET. The previous analyst recommendation was Market Perform.OKTA was trading at $89.96 at issue of...

June 3, 2024   OKTA -0.74%

UBS analyst issues UNDERPERFORM recommendation for OKTA on June 3, 2024 10:00AM ET. The previous analyst recommendation was Underperform.OKTA was trading at $89.96 at issue of the analyst...

June 3, 2024   OKTA -0.74%

Keefe, Bruyette & Woods analyst issues OUTPERFORM recommendation for MDB on June 3, 2024 09:55AM ET. MDB was trading at $242.53 at issue of the analyst recommendation.The overall...

June 3, 2024   MDB -1.65%

HSBC analyst issues HOLD recommendation for MDB on June 3, 2024 09:55AM ET. MDB was trading at $242.53 at issue of the analyst recommendation.The overall analyst consensus :...

June 3, 2024   MDB -1.65%

Oppenheimer analyst issues BUY recommendation for CPRX on June 3, 2024 09:00AM ET. The previous analyst recommendation was Buy.CPRX was trading at $16.38 at issue of the analyst...

June 3, 2024   CPRX -0.68%

H.C. Wainwright analyst issues UNDERPERFORM recommendation for CPRX on June 3, 2024 09:00AM ET. The previous analyst recommendation was Underperform.CPRX was trading at $16.38 at issue of the...

June 3, 2024   CPRX -0.68%

Oppenheimer analyst issues BUY recommendation for CPRX on June 3, 2024 09:00AM ET. The previous analyst recommendation was Buy.CPRX was trading at $16.38 at issue of the analyst...

June 3, 2024   CPRX -0.68%

Lake Street analyst issues BUY recommendation for HROW on June 3, 2024 08:56AM ET. The previous analyst recommendation was Buy.HROW was trading at $18.125 at issue of the...

June 3, 2024   HROW 0.68%